Q4 2024 · 13F-HR
72 Investment Holdings, LLCholdings as filed
Filed 2025-02-14 · accession 0000902664-25-001046
$49.1M
Reported value
7
Positions
2024-12-31
Period end
The Brief · 72 Investment Holdings, LLC · Q4 2024
AI · grounded in 13F
72 Investment Holdings, LLC reported no changes to its 13F holdings for 2024-12-31 relative to 2024-09-30.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $29.4M | 59.8% | 1,017,751 | Common | SHARED |
| 500946108 | KRRO | KORRO BIO INC | $10.5M | 21.5% | 276,831 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $5.1M | 10.3% | 65,933 | Common | SHARED |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $2.8M | 5.75% | 667,778 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $753,767 | 1.53% | 474,067 | Common | SHARED |
| 90042W100 | — | TURNSTONE BIOLOGICS CORP | $273,285 | 0.56% | 549,980 | Common | SHARED |
| 68217N105 | — | OMEGA THERAPEUTICS INC | $263,153 | 0.54% | 352,941 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.